Healthcare Tracked since Q4 FY26 - Q4 FY26

Cohance Lifesciences Ltd

COHANCELIFESCIENCES

Latest quarter Q4 FY26

Revenue ₹619 Cr (-13% YoY)

Management credibility Building

Needs more scored promises across 1 quarters

Latest signal bearish high

Cohance Lifesciences reported FY26 revenue of ₹22.68B, down 13% YoY, with adjusted EBITDA margin of 21% (standalone 2...

Quarterly Earnings Timeline

Financial verification status, call summary, sentiment, and management-delivery signals by quarter.

1 quarter

Q4 FY26 15 May 2026

Revenue ₹619 Cr (-13% YoY)

Cohance Lifesciences reported FY26 revenue of ₹22.68B, down 13% YoY, with adjusted EBITDA margin of 21% (standalone 24.6%).